By Stuart H. Orkin, MD, Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute; David G. Nathan Professor of Pediatrics, Harvard Medical School; Investigator, Howard Hughes Medical Institute, Boston, MA; David E. Fisher, MD, PhD, Professor of Pediatrics, Harvard Medical School, Boston, MA; A. Thomas Look, MD, Division of Pediatrics, Dana Farber Cancer Institute, Boston, MA; Samuel E. Lux, IV; David Ginsburg, MD, Professor of Medicine, Howard Hughs Medical Institute, University of Michigan School of Medicine, Ann Arbor, MI; and David G. Nathan, MD, President Emeritus, Dana-Farber Cancer Institue, Robert A. Stranahan Distinguished Professor of Pediatrics, Harvard Medical School, Boston, MA |